Microinvasive carcinoma of the breast

International Journal of Surgical Pathology

Volumn 6, Issue 4, 1998, Pages 183-188

  Schnitt, Stuart J ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Ductal carcinoma in situ; Microinvasion

Indexed keywords

BREAST CARCINOMA; CANCER CLASSIFICATION; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INVASIVE CARCINOMA; MICROSCOPIC ANATOMY; NOMENCLATURE; PRIORITY JOURNAL; REVIEW;

EID: 0031738929     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/106689699800600401     Document Type: Review

References (27)

1. American Joint Committee on Cancer. AJCC cancer staging manual. Lippincott-Raven, Philadelphia, pp. 172-173, 1997
2. Schuh ME, Nemoto T, Penetrante R, et al. Intraductal carcinoma. Analysis of presentation, pathologic findings, and outcome of disease. Arch Surg 121:1303-1307, 1986
3. Rosner D, Lane WW, Penetrante R. Ductal carcinoma in situ with microinvasion. A curable entity using surgery alone without need for adjuvant therapy. Cancer 67:1498-1503, 1991
4. Wong JH, Kopald KH, Morton DL. The impact of microinvasion on axillary node metastases and survival in patients with intraductal breast cancer. Arch Surg 125:1298-1302, 1990
5. Solin LJ, Fowble BL, Yeh I-T, et al. Microinvasive ductal carcinoma of the breast treated with breast-conserving surgery and definitive irradiation. Int J Radiat Oncol Biol Phys 23:961-968, 1992
6. Patchefsky AS, Schwartz GF, Finkelstein SD, et al. Heterogeneity of intraductal carcinoma of the breast. Cancer 63:731-734, 1989
7. Silver SA, Tavassoli FA. Mammary ductal carcinoma in situ with microinvasion. Cancer 82:2382-2390, 1998
8. Fisher ER. Pathobiological considerations relating to the treatment of intraductal carcinoma (ductal carcinoma in situ) of the breast. CA Cancer J Clin 47:52-64, 1996
9. Kerner H, Lichtig C. Lobular cancerization: Incidence and differential diagnosis with lobular carcinoma in situ of breast. Histopathol 10:621-629, 1986
10. Eusebi V, Collina G, Bussolati G. Carcinoma in situ in sclerosing adenosis of the breast: An immunocytochemical study. Semin Diagn Pathol 6:146-152, 1989
11. Oberman HA, Markey BA. Noninvasive carcinoma of the breast presenting in adenosis. Mod Pathol 4:31-35, 1991
12. Youngson BJ, Cranor M, Powell C, Rosen PP. Epithelial displacement in surgical breast specimens following needling procedures. Am J Surg Pathol 18:896-903, 1994
13. Youngson BJ, Liberman L, Rosen PP. Displacement of carcinomatous epithelium in surgical breast specimens following stereotaxic core biopsy. Am J Clin Pathol 103:698-702, 1995
14. Lagios MD. Microinvasion in ductal carcinoma in situ. In Silverstein MJ (ed). Ductal carcinoma in situ of the breast. Baltimore, Williams and Wilkins, pp. 241-246, 1997
15. Barsky SH, Siegal GP, Janotta F, Liotta LA. Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Invest 49:140-147, 1983
16. Sakr WA, Zarbo RJ, Crissman JD. Immunohistologic distribution of basement membrane in breast neoplasia. Surg Pathol 1:3-12, 1988
17. Hijazi YM, Lessard JL, Weiss MA. Use of anti-actin and S-100 protein antibodies in differentiating benign and malignant sclerosing breast lesions. Surg Pathol 2:125-135, 1989
18. Gottlieb C, Raju U, Greenawald KA. Myoepithelial cells in the differential diagnosis of complex benign and malignant breast lesions: An immunohistochemical study. Mod Pathol 3:135-140, 1990
19. Joshi M, Lee AKC, Pedersen CA, Schnitt S, Camus MG, Hughes KS. The role of immunocytochemical markers in the differential diagnosis of proliferative and neoplastic lesions of the breast. Mod Pathol 9:57-62, 1996
20. Dwarkanath S, Lee AKC, Delellis RA, Silverman ML, Frasca L, Wolfe HJ. S-100 protein positivity in breast carcinomas: A potential pitfall in diagnostic immunohistochemistry. Hum Pathol 18:1144-1148, 1987
21. Wang NP, Wan BC, Skelly M, Frid MG, Glukhova MA, Koteliansky VE, Gown AM. Antibodies to novel myoepithelium-associated proteins distinguish between benign lesions and carcinoma in situ from invasive carcinoma of the breast. Appl Immunohistochem 5:141-151, 1997
22. Page DL, Anderson TJ (eds). Diagnostic histopathology of the breast. Churchill Livingstone, Edinburgh, p. 279, 1987
23. Elston CW, Ellis IO (eds). The breast. Churchill Livingstone, Edinburgh, p. 242, 1998
24. Silverstein MJ. Ductal carcinoma in situ with microinvasion. In Silverstein MJ (ed). Ductal carcinoma in situ of the breast. Baltimore, Williams and Wilkins, pp. 557-562, 1997
25. Akhtar S, Zablow A, Michaelson RA, Hutter RVP, Leitner SP. Predictors of axillary lymph node metastases in small (one centimeter or less) T1a,b primary breast cancer (abstract). J Clin Oncol 17:120a, 1998
26. Penault-Llorca F, Le Bouedec G, Pomel C, Feillel V, Dauplat J, de Latour M. Microinvasive carcinoma of the breast: Is axillary lymph node dissection indicated? (abstract). Lab Invest 78:25A, 1998
27. Prasad ML, Giri G, Hoda S. Clinicopathologic features of microinvasive (<1 mm) carcinoma of the breast (abstract). Lab Invest 78:25A, 1998